This is a phase II, multicenter, open label, single arm, non-randomized trial using Simon's optimal two-stage design to evaluate the efficacy of cemiplimab in …

Kidney Transplant RecipientCutaneous Squamous Cell Carcinoma (CSCC)Advanced Cutaneous Squamous Cell Carcinoma+1 more

~Estimated

~$75 – $2,000

Actual pay is set by the research site.

Washington University School of MedicineNCT07715734

Phase 2

A Phase 2 Study of Intratumoral Administration of L19IL2/L19TNF in Locally Advanced Cutaneous Squamous Cell Carcinoma Patients Progressing on or Intolerant to Systemic Treatment

Open-label, single-arm, multicenter study in patients with locally advanced, histologically confirmed Cutaneous Squamous Cell Carcinoma (LacSCC) amenable to in…

Locally Advanced Cutaneous Squamous Cell Carcinoma

~Estimated

~$75 – $3,000

Actual pay is set by the research site.

Philogen S.p.A.NCT07228442